Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
MEI Pharma Inc
Swot
MEI Pharma Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
MEI Pharma Inc has 12 Strengths, 10 Weaknesses, 3 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(12)
Weakness
(10)
Opportunity
(3)
Threats
(0)
Others
(0)
MACD Crossover Above Signal Line
Significant (over 30%) distance from 52 week high
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Week
MACD crossed above signal line previous end of day
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Company with No Debt
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Increasing profits every quarter for the past 2 quarters
Stock with Low PE (PE < = 10)
Stocks with Quarter Change % less than Industry
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Near 52 Week Low
Declining Net Cash Flow : Companies not able to generate net cash
Book Value Per Share deteriorating for last 2 years
Weak Momentum: Price below Short, Medium and Long Term Averages
RSI indicating price weakness
Near 52 Week Low
Stocks Underperforming their Industry Price Change in the Quarter
Institutions increasing their shareholding
Mutual Funds Increased Shareholding over the Past Two Months
MFs increased their shareholding last quarter
